ONO-7300243

N/A

Report date: 2021/12/07 16:28:47
NME

Base Information

Drug NameONO-7300243
Drug Alias NameONO-7300243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOno Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A